Correlation Between Inhibrx and Sutro Biopharma

Can any of the company-specific risk be diversified away by investing in both Inhibrx and Sutro Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Sutro Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Inhibrx and Sutro Biopharma, you can compare the effects of market volatilities on Inhibrx and Sutro Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Sutro Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Sutro Biopharma.

Diversification Opportunities for Inhibrx and Sutro Biopharma

0.21

Correlation Coefficient

Inhibrx  Sutro Biopharma

Modest diversification

The 3 months correlation between Inhibrx and Sutro is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Sutro Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sutro Biopharma and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Sutro Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sutro Biopharma has no effect on the direction of Inhibrx i.e., Inhibrx and Sutro Biopharma go up and down completely randomly.

Pair Corralation between Inhibrx and Sutro Biopharma

Given the investment horizon of 90 days Inhibrx is expected to generate 0.53 times more return on investment than Sutro Biopharma. However, Inhibrx is 1.88 times less risky than Sutro Biopharma. It trades about 0.02 of its potential returns per unit of risk. Sutro Biopharma is currently generating about -0.14 per unit of risk. If you would invest  1,388  in Inhibrx on December 19, 2024 and sell it today you would earn a total of  12.00  from holding Inhibrx or generate 0.86% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Inhibrx  vs.  Sutro Biopharma

Inhibrx

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Inhibrx are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong fundamental drivers, Inhibrx is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Sutro Biopharma

Risk-Adjusted Performance

Very Weak

Over the last 90 days Sutro Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Inhibrx and Sutro Biopharma

The main advantage of trading using opposite Inhibrx and Sutro Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Sutro Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sutro Biopharma will offset losses from the drop in Sutro Biopharma's long position.

The idea behind Inhibrx and Sutro Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.